Home ■ Participation ■ Modules/tests ■ Assessments ■ Epitopes ■ Protocols ■ Techniques ■ Links

 Organization  ■  Subscription  ■  Newsletter  ■  Accompanying letters  ■  Seminars           

NordiQC runs

Run 45 (general module), B20 (breast cancer module) and H8 (HER-2 ISH module): Results are available, see Newsletter

Run 46 (general module), B21 (breast cancer module) and H9 (HER-2 ISH module): The website is opens for protocol submission: Participation

NordiQC teaching events

NordiQC Workshop in Diagnostic Immunohistochemistry
Aalborg, Denmark, 19-21 September 2016

3rd NordiQC Conference in Diagnostic Immunohistochemistry
Aalborg, Denmark, 9-12 June2017

Photo: SOX10 staining breast (A-B) and malignant melanoma (C-D). With an optimal protocol (A and C), the breast myoepithelial cells are strongly stained and the low expressor tumour cells weakly stained. With a suboptimal protocol (B and D), the myoepithelial cells are weakly stained, while the melanoma is false negative.
 Companies sponsoring NordiQC scientific work have no influence on methods or results

Update: 2015.12.17

Apply for participation in NordiQC
NordiQC is an independent scientific organization, promoting the quality of immunohistochemistry by arranging schemes for pathology laboratories, assessing tissue based assays, giving guidelines for improvement and providing good protocols.